Bioniche Life Sciences Inc.

Bioniche has evolved into a research-based, technology-driven Canadian biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide. Key areas of strategic focus for Bioniche include developing effective therapies for bladder cancer and potentially other cancers; a cattle vaccine to help prevent E. coli O157:H7 infection; and technologies to improve reproduction and potentially replace the use of antibiotics in livestock.